Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine

Clinical trial NCT04691908 · COMPLETED

Trial details

NCT number: NCT04691908
Sponsor: Research Institute for Biological Safety Problems
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Covid19 SARS-CoV Infection Vaccine Adverse Reaction

Start date: 2020-12-25
Primary completion: 2021-04-26
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.